This Media centre is for NDLR relevant industry news provided by the NDLR Organising Committee Members, Media Partners, Sponsors and Exhibitors. If you wish to submit an article for consideration please email the details to the NDLR Meeting Organiser at email@example.com.
See Kimberly Stegmaire, one of NDLR 2018 invited speakers paper on Fred Hutch researchers engineer complex TCR immunotherapy that may target relapsing leukemia
See Kimberly Stegmaire, one of NDLR 2018 invited speakers paper on Cancer researchers hit a bullseye with new drug target for Ewing sarcoma.
See Bruce Levine, one of NDLR 2018 invited speakers webinar on “What’s next for CAR T Cell Immunotherapy.
July 3, 2017
Charting the genomic landscape of T-lineage acute lymphoblastic leukemia patients revealed insights that will guide research and help to lay the foundation for more targeted therapy.
June 28, 2017
Stem-cell researchers solve mystery of relapse in acute myeloid leukemia.
Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.
June 13, 2017
New frontier in cancer care: Turning blood into living drugs
March 08 2017
11 year study shows an estimated overall survival rate of 83.3 % according to National Cancer Institute.